Wuhan Dazhong Dental Medical Co. Ltd. announced its unaudited consolidated financial results for the six months ended 30 June 2025. The company reported a 9.2% decrease in revenue, amounting to RMB185.8 million compared to RMB204.5 million in the same period in 2024. This decline was primarily attributed to a reduction in revenue across all business lines, with general dentistry services decreasing by 7.9% to RMB102.0 million, implantology services dropping by 10.5% to RMB53.6 million, and orthodontics services falling by 10.9% to RMB30.2 million. The cost of sales also saw a decrease of 10.9%, down from RMB129.7 million for the first half of 2024 to RMB115.5 million for the corresponding period in 2025. The reduction in costs was mainly due to lower expenses in consumables and customized products, staff costs, and depreciation and amortization. The company did not provide any specific outlook or guidance for future periods within this announcement.